OneSource Specialty Pharma revises 19th AGM time to 5 pm
- OneSource Specialty Pharma reschedules its 19th AGM to 5:00 pm IST
- The meeting is held on September 23, 2026, via VC/OAVM
- It is the company's second annual general meeting after listing
- Electronic notices and annual reports for FY26 are available online

*this image is generated using AI for illustrative purposes only.
OneSource Specialty Pharma Limited has revised the timing of its 19th Annual General Meeting. The session, scheduled for September 23, 2026, will now commence at 5:00 pm IST instead of the previously announced 11:00 am slot.
The company confirmed the update in a filing dated August 31, 2026. This marks the second AGM for the firm post-listing. The meeting will continue to be conducted through Video Conferencing or Other Audio Visual Means (VC/OAVM).
Revised Meeting Details
| Detail | Information |
|---|---|
| Date | September 23, 2026 |
| Time | 5:00 pm |
| Mode | VC / OAVM |
| Platform | National Securities Depository Limited |
Shareholder Participation
Shareholders can join and participate in the AGM only through the VC/OAVM facility. The company will send the notice and annual report for the financial year 2025-26 electronically to members with registered email addresses. These documents are also available on the company website and stock exchange portals.
The company provides a remote e-voting facility for all resolutions. Members who do not vote remotely can exercise their voting rights during the AGM via the e-voting system. Mr. Pradeep Bheemsen Kulkarni of M/s. V Sreedharan & Associates has been appointed as the scrutinizer for the voting process.
Historical Stock Returns for Onesource Specialty Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.71% | -0.27% | +3.45% | +9.03% | -13.74% | -7.14% |
What strategic resolutions or executive appointments are expected to be tabled at the upcoming AGM that could signal OneSource's growth trajectory for FY26-27?
How might the shift to a late-afternoon meeting time impact shareholder participation rates and voting turnout compared to previous sessions?
Does the company plan to transition from VC/OAVM to hybrid or in-person meetings in future fiscal years to enhance stakeholder engagement?


































